Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06787443 · ClinicalTrials.gov registry record · NA
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
A NA study, sponsored by Olly, PBC.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT06787443: Completed NA study, sponsored by Olly, PBC.
NCT06787443 is a NA study that has completed, run by Olly, PBC. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06787443, a NA study, has completed, sponsored by Olly, PBC.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Dietary Supplement with Proprietary Herbal Extract Blend and GABA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2024-05-10 |
| Est. Completion | 2024-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06787443
The ClinicalTrials.gov registry entry for NCT06787443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olly, PBC, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06787443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06787443 about?
NCT06787443 is a clinical study titled "Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms". The objective of this study is to assess the safety and effectiveness of a dietary supplement for symptom relief in subjects with menopausal symptoms over the course of five weeks of continuous daily use.
What is the current status of trial NCT06787443?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2024-05-10. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT06787443?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Dietary Supplement with Proprietary Herbal Extract Blend and GABA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06787443?
This trial is sponsored by Olly, PBC, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.